For all media related queries, please contact the UK Novo Nordisk Communications team

Tel: +44 (0)1403 286480



For out of hours enquiries, please contact Novo Nordisk, Global Media Relations

Tel: +45 4444 8888

Link to full press release

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See for how to report side effects.